Cargando…

P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION

Detalles Bibliográficos
Autores principales: Yoon, Sung-Soo, LI, Zhiming, Zhou, Keshu, Zhou, Xiaoxi, Guo, Ye, Zhang, Huilai, Eom, Ki-Seong, Jin Kim, Seok, Yong Oh, Sung, Lim, Sungnam, Youssoufian, Hagop, Jiang, Vernon C, Huang, Zanchun, Kilfoil, Georgina, Wang, Xin, Cao, Zhixiang, LI, Xiang, Wu, Alexander, Chen, Yiyou, Song, Yuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431014/
http://dx.doi.org/10.1097/01.HS9.0000971564.58268.80
_version_ 1785091098248478720
author Yoon, Sung-Soo
LI, Zhiming
Zhou, Keshu
Zhou, Xiaoxi
Guo, Ye
Zhang, Huilai
Eom, Ki-Seong
Jin Kim, Seok
Yong Oh, Sung
Lim, Sungnam
Youssoufian, Hagop
Jiang, Vernon C
Huang, Zanchun
Kilfoil, Georgina
Wang, Xin
Cao, Zhixiang
LI, Xiang
Wu, Alexander
Chen, Yiyou
Song, Yuqin
author_facet Yoon, Sung-Soo
LI, Zhiming
Zhou, Keshu
Zhou, Xiaoxi
Guo, Ye
Zhang, Huilai
Eom, Ki-Seong
Jin Kim, Seok
Yong Oh, Sung
Lim, Sungnam
Youssoufian, Hagop
Jiang, Vernon C
Huang, Zanchun
Kilfoil, Georgina
Wang, Xin
Cao, Zhixiang
LI, Xiang
Wu, Alexander
Chen, Yiyou
Song, Yuqin
author_sort Yoon, Sung-Soo
collection PubMed
description
format Online
Article
Text
id pubmed-10431014
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310142023-08-17 P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION Yoon, Sung-Soo LI, Zhiming Zhou, Keshu Zhou, Xiaoxi Guo, Ye Zhang, Huilai Eom, Ki-Seong Jin Kim, Seok Yong Oh, Sung Lim, Sungnam Youssoufian, Hagop Jiang, Vernon C Huang, Zanchun Kilfoil, Georgina Wang, Xin Cao, Zhixiang LI, Xiang Wu, Alexander Chen, Yiyou Song, Yuqin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431014/ http://dx.doi.org/10.1097/01.HS9.0000971564.58268.80 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Yoon, Sung-Soo
LI, Zhiming
Zhou, Keshu
Zhou, Xiaoxi
Guo, Ye
Zhang, Huilai
Eom, Ki-Seong
Jin Kim, Seok
Yong Oh, Sung
Lim, Sungnam
Youssoufian, Hagop
Jiang, Vernon C
Huang, Zanchun
Kilfoil, Georgina
Wang, Xin
Cao, Zhixiang
LI, Xiang
Wu, Alexander
Chen, Yiyou
Song, Yuqin
P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION
title P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION
title_full P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION
title_fullStr P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION
title_full_unstemmed P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION
title_short P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION
title_sort p1167: treatment of relapsed/refractory hgbcl with myc rearrangement: a multicenter, open-label, phase 2 study of pc-002(sepb),a first-in-class inhibitor of deubiquitinases targeting myc degradation
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431014/
http://dx.doi.org/10.1097/01.HS9.0000971564.58268.80
work_keys_str_mv AT yoonsungsoo p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT lizhiming p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT zhoukeshu p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT zhouxiaoxi p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT guoye p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT zhanghuilai p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT eomkiseong p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT jinkimseok p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT yongohsung p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT limsungnam p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT youssoufianhagop p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT jiangvernonc p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT huangzanchun p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT kilfoilgeorgina p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT wangxin p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT caozhixiang p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT lixiang p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT wualexander p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT chenyiyou p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation
AT songyuqin p1167treatmentofrelapsedrefractoryhgbclwithmycrearrangementamulticenteropenlabelphase2studyofpc002sepbafirstinclassinhibitorofdeubiquitinasestargetingmycdegradation